- Federal health regulators have fast-tracked approvals for coronavirus research, allowing scientists across the nation to skip through months of red tape.
- Researchers at NYU Langone on March 24 launched one of the nation’s largest hydroxychloroquine studies and enrolled their first patient 10 days later.
- It’s one of more than a dozen formal studies in the U.S. looking at the treatment for Covid-19, according to ClinicalTrials.gov.
Read the original article here: https://www.cnbc.com/2020/04/15/coronavirus-us-clinical-trials-of-hydroxychloroquine-hit-warp-speed.html